Tvardi Therapeutics was incorporated in the state of Delaware in December 2017.
The Company’s headquarters are located at 3 Sugar Creek Center Blvd Suite 525, Sugar Land, TX 77478. The main office phone number is (713) 489-8654.
Tvardi’s stock is traded on the Nasdaq Capital Market under the symbol TVRD. The Reverse Merger (RM) with Cara Therapeutics was completed on April 15, 2025.
The CUSIP number for the Tvardi’s common stock is 140755 307.
Tvardi does not currently have a direct stock purchase plan
Tvardi does not currently offer a dividend reinvestment program and does not expect to declare or pay dividends on our common stock in the foreseeable future.
Equiniti Trust Company
1110 Centre Pointe Curve
Suite 101
Mendota Heights, MN 55120
800-937-5449
https://equiniti.com/us/
If your shares are held in street name (i.e., through your brokerage account), you must contact your broker.
If your shares held directly by you in your name, please contact our transfer agent:
Equiniti Trust Company
1110 Centre Pointe Curve
Suite 101
Mendota Heights, MN 55120
800-937-5449
The Company’s fiscal year ends on December 31.
Our legal counsel is:
Cooley LLP
55 Hudson Yards
New York, New York 10001
+1 (212) 479-6000